Effect of Five Commercial Probiotic Formulations on Candida Albicans Growth: In Vitro Study

Purpose: The objective was to evaluate the antagonistic effect of Lactobacillus and Bifidobacterium recovered from five commercial probiotics on the growth of C. albicans. Study design: The Lactobacillus and Bifidobacterium strains of five commercial probiotics were recovered and grown: Probio Hp+®, ProBiseis®, Lactipan®, Liolactil®, and Lacteol Fort®; 50 mg of each was hydrated and grown in Lactobacilli MRS (De Man, Rogosa and Sharpe) broth and incubated at 37°C with stirring (120 RPM) for 24 hours. Serial dilutions of 10-1 to 10-7 were made and viability was verified and quantified. For the antagonism tests, a suspension/ inoculum of Lactobacillus strains recovered from each commercial preparation (4-30 x 109 ) and C. albicans ATCC 90028 (1.5-8 x 108 ) was prepared in MRS broth and incubated for 48 hours at 36°C, then plated on Dextrose Sabouraud Agar with Chloramphenicol and Rogosa Agar and the colony-forming units (CFU) were quantified. Additionally, viability was evaluated using the LIVE/DEAD® Yeast and Bacterial Viability kit. Results: The probiotic that produced the highest acidity of the medium was Lactipan®, followed by Probiseis® and Liolactil®, while Probio Hp+® showed the least change. Probiseis® was determined to have the highest growth of probiotic bacteria and the highest inhibition on C. albicans, followed by Lactipan®; Liolactil® and ProbioHp+® showed the least effect. In fluorescence tests, ProBiseis® showed the best effect, followed by Liolactil® and Lactipan®; Probio Hp+® had less of an effect. Conclusions: Two commercial products (ProBiseis and Lactipan) whose formulations have L. acidophilus, L. casei, L. rhamnosus, L. plantarum, B. infantis, and S. thermophilus have a greater inhibitory effect on C. albicans ATCC 90028

Candida albicans; Antagonistic effect; Lactobacillus; Colonization

1. Reid G, Jass J, Sebulsky MT, McCormick JK. Potential uses of probiotics in clinical practice. Clin Microbiol Rev;16(4):658-672. 2003.

2. Köhler GA, Assefa S, Reid G. Probiotic interference of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 with the opportunistic fungal pathogen Candida albicans. Infect Dis Obstet Gynecol;636474. 2012.

3. Mendonça FHBP, Santos SSF dos, Faria I da S de, Gonçalves e Silva CR, Jorge AOC, Leão MVP. Effects of probiotic bacteria on Candida presence and IgA anti-Candida in the oral cavity of elderly. Braz Dent J;23(5):534- 538. 2012.

4. Strus M, Kucharska A, Kukla G, Brzychczy-Włoch M, Maresz K, Heczko PB. The in vitro activity of vaginal Lactobacillus with probiotic properties against Candida. Infect Dis Obstet Gynecol;13(2):69-75. 2005.

5. Hatakka K, Ahola AJ, Yli-Knuuttila H, Richardson M, Poussa T, Meurman JH, Korpela R. Probiotics reduce the prevalence of oral candida in the elderly-a randomized controlled trial. J Dent Res;86(2):125-130. 2007.

6. Manzoni P, Mostert M, Leonessa ML, Priolo C, Farina D, Monetti C, Latino MA, Gomirato G. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. Clin Infect Dis Off Publ Infect Dis Soc Am;42(12):1735-1742. 2006.

7. Matsubara VH, Silva EG, Paula CR, Ishikawa KH, Nakamae AEM. Treatment with probiotics in experimental oral colonization by Candida albicans in murine model (DBA/2). Oral Dis;18(3):260-264. 2012.

8. Sleator RD. Designer probiotics: Development and applications in gastrointestinal health. World J Gastrointest Pathophysiol;6(3):73-78. 2015.

9. Van den Nieuwboer M, Brummer RJ, Guarner F, Morelli L, Cabana M, Claasen E. The administration of probiotics and synbiotics in immune compromised adults: is it safe? Benef Microbes;6(1):3-17. 2015.

10. Ozen M, Dinleyici EC. The history of probiotics: the untold story. Benef Microbes;6(2):159-165. 2015.

11. Miranda, NMG. Probióticos y micronutrimentos ¿Son útiles para el tratamiento de la diarrea aguda? Boletín médico del Hospital Infantil de México;65:157-166. 2008.

12. Li D, Li Q, Liu C, Lin M, Li X, Xiao X, Zhu Z, Gong Q, Zhou H. Efficacy and safety of probiotics in the treatment of Candida-associated stomatitis. Mycoses;57(3):141-146. 2014.

13. Song YG, Lee SH. Inhibitory effects of Lactobacillus rhamnosus and Lactobacillus casei on Candida biofilm of denture surface. Arch Oral Biol;76:1-6. 2017.

14. Ribeiro FC, de Barros PP, Rossoni RD, Junqueira JC. Jorge AO. Lactobacillus rhamnosus inhibits Candida albicans virulence factors in vitro and modulates immune system in Galleria mellonella. J Appl Microbiol;122(1):201-211. 2017.

15. Manzoni P. Use of Lactobacillus casei subspecies Rhamnosus GG and gastrointestinal colonization by Candida species in preterm neonates. J Pediatr Gastroenterol Nutr;3:190-194. 2007.

16. Matsubara VH, Wang Y, Bandara HMHN, Mayer, MPA, Samaranayake LP. Probiotic lactobacilli inhibit early stages of Candida albicans biofilm development by reducing their growth, cell adhesion, and filamentation. Appl Microbiol Biotechnol;100: 6415-6426. 2016.

17. Rossoni RD, de Barros PP, de Alvarenga JA, de Camargo Ribeiro F, Velloso MDS, Fuchs BB, Mylonakis E, Cardoso JAO, Junqueira JC. Antifungal activity of clinical Lactobacillus strains against Candida albicans biofilms: identification of potential probiotic candidates to prevent oral candidiasis. Biofouling;34:212-225. 2018.

18. Coman MM, Verdenelli MC, Cecchini C, Silvi S, Orpianesi C, Boyko N, Cresci A. In vitro evaluation of antimicrobial activity of Lactobacillus rhamnosus IMC 501®, Lactobacillus paracasei IMC 502® and SYNBIO® against pathogens. J Appl Microbiol;117:518-527. 2014.

19. Kumar S, Singhi S. Role of probiotics in prevention of Candida infection in critically ill children. Mycoses;56(3):204-211. 2013.

20. Villena J, Salva S, Agüero G, Alvarez S. Immunomodulatory and protective effect of probiotic Lactobacillus casei against Candida albicans infection in malnourished mice. Microbiol Immunol;55(6):434-445. 2011.

21. Mailänder-Sánchez D, Wagener J, Schaller M. Potential role of probiotic bacteria in the treatment and prevention of localised candidosis. Mycoses;55(1):17-26. 2012.

22. Zwolińska-Wcisło M, Brzozowski T, Mach T, Budak A, Trojanowska D, Konturek PC, Pajdo R, Drozdowicz D, Kwiecien S. Are probiotics effective in the treatment of fungal colonization of the gastrointestinal tract? Experimental and clinical studies. J Physiol Pharmacol Off J Pol Physiol Soc;57 Suppl 9:35-49. 2006.

23. Hasslöf P, Hedberg M, Twetman S, Stecksén-Blicks C. Growth inhibition of oral mutans streptococci and candida by commercial probiotic lactobacilli–an in vitro study. BMC Oral Health;10:18. 2010.

24 Verdenelli MC, Ghelfi F, Silvi S, Orpianesi C, Cecchini C, Cresci A. Probiotic properties of Lactobacillus rhamnosus and Lactobacillus paracasei isolated from human faeces. Eur J Nutr;48(6):355-363. 2009.

25 Tang H, Ren J, Yuan J, Zeng B, Wei H. An in vitro assessment of inhibitory effect of 16 strains of probiotics on the germination of Candida albicans. AFR J Microbiol Res;4:1251-1256. 2010.

26 Reid G, Tieszer C, Lam D. Influence of lactobacilli on the adhesion of Staphylococcus aureus and Candida albicans to fibers and epithelial cells. J Ind Microbiol;15(3):248-253. 1995.